Table III.
Complications.
Variable | Total (%) | ≤ 65 | > 65 | p-value | < 70 | ≥ 70 | p-value |
---|---|---|---|---|---|---|---|
n | 1,004 | 430 | 574 | 597 | 407 | ||
NJR notifiable | |||||||
Revision, n (%) | |||||||
DAIR | 7 (0.7) | 1 | 6 | 4 | 3 | ||
Revision for dislocation | 3 (0.3) | 1 | 2 | 2 | 1 | ||
Traumatic periprosthetic fracture | 3 (0.3) | 3 | 1 | 2 | |||
Total | 13 (1.3) | 2 (0.5) | 11 (1.9) | 0.382 | 7 (1.2) | 6(1.5) | 0.871 |
Re-revision, n (%) | |||||||
Aseptic loosening femoral component (previous DAIR) | 1 (0.1) | 1 | 1 | ||||
Death within 90 days, n (%) | 3 (0.3) | 1 (0.2) | 2 (0.3) | 1 (0.2) | 2 (0.5) | ||
Non NJR notifiable | |||||||
Intraoperative*, n (%) | |||||||
Calcar crack and cable | 10 (1.0) | 4 | 6 | 6 | 4 | ||
GT fracture and cable | 1 (0.1) | 1 | 1 | ||||
Postoperative, n (%) | |||||||
Transient fem nerve palsy | 1 (0.1) | 1 | 1 | ||||
Community cardiac arrest | 1 (0.1) | 1 | 1 | ||||
Dislocation × 1 | 6 (0.6) | 2 | 4 (1 open reduction) | 4 | 2 (1 open reduction) | ||
Dislocation × 2 | 1 (0.1) | 1 | 1 | ||||
Dislocation × 3 | 1 (0.1) | 1 | 1 | ||||
Irreducible dislocation | 1 (0.1) | 1 | 1 | ||||
(All dislocation including revision) | 12 (1.2) | 3 | 9 | 0.892 | 6 | 6 | 0.968 |
Traumatic PP fracture (conservative) | 5 (0.5) | 1 | 4 | 2 | 3 | ||
ORIF B1 fracture | 2 (0.2) | 2 | 2 | ||||
(All postop fractures including revision) | 10 (1.0) | 1 | 9 | 0.801 | 3 | 7 | 0.856 |
(All operative fractures, B1 and B2) | 5 (0.5) | 5 | 1 | 4 | |||
Postop myocardial infarction | 1 (0.1) | 1 | 1 | ||||
Postop pulmonary embolus | 1 (0.1) | 1 | 1 | ||||
Aseptic loosening femoral component (surveillance) | 1 (0.1) | 1 | 1 | ||||
Total non-notifiable | 32 (3.2) | 9 | 23 | 0.204 | 14 | 18 | 0.861 |
All complications | 48 (4.8) | 12/430 | 36/574 | 0.802 | 23/597 | 25/407 | 0.856 |
MDS recorded but not published.
DAIR, debridement, antibiotics, and implant retention; GT, greater trochanter; NJR, National Joint Registry; ORIF, open reduction, internal fixation.; PP, periprosthetic